The clinical spectrum of clostridium difficile colitis in immunocompromised patients

American Surgeon

Volumn 62, Issue 7, 1996, Pages 603-607

  Schweitzer, Michael A ^a   Sweiss, Iliana ^a   Silver, Dana L ^a   Stellato, Thomas A ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HOSPITAL INFECTION; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PSEUDOMEMBRANOUS COLITIS;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; METRONIDAZOLE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VANCOMYCIN;

EID: 0029931521     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Talbot RW, Walker RC, Beart RW. Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis. Br J Surg 1986;73:457-60.
2. Jobe BA, Grasley A, Deveney KE, et al. Clostridium difficile colitis: An increasing hospital-acquired illness. Am J Surg 1995; 169:480-3.
3. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
4. Young G, McDonald M. Antibiotic-associated colitis: Why do patients relapse? Gastroenterology 1986;90:1098-9.
5. Barany P, Stenvinkel P, Nord CE, et al. Clostridium difficile infection - a poor prognostic sign in uremic patients? Clin Nephr 1992;38:53-7.
6. Rosenberg JM, Walker M, Welch JP, et al. Clostridium difficile colitis in surgical patients. Am J Surg 1984;147:486-91.
7. Nielsen H, Daugaard G, Tvede M, et al. High prevalence of Clostridium difficile diarrhoea during intensive chemotherapy for disseminated germ cell cancer. Br J Cancer 1992;66:666-7.
8. Kamthan AG, Bruckner HW, Hirschman SZ, et al. Clostridium difficile diarrhea induced by cancer chemotherapy. Arch Int Med 1992;152:1715-7.
9. Church JM, Fazio VW. A role for colonic stasis in the pathogenesis of disease related to Clostridium difficile. Dis Colon Rectum 1986;29:804-9.
10. Pierce PF Jr, Wilson R, Silvia J Jr, et al. Antibiotic-associated pseudomembranous colitis: An epidemiologic investigation of a cluster of cases. J Infect Dis 1982;145:269-74.
11. Pittman FE. Lomotil and antibiotic colitis. Ann Intern Med 1975;83:124-5.
12. Bolton RP, Culshaw MA. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut 1986;27:1169-72.
13. Gerding DN, Olson MM, Peterson LR. Cumulative treatment experience with 697 cases of Clostridium difficile diarrhea. Abstract of 29th Interscience Conference on Antimicrobial Chemotherapy, Houston. Washington, DC: American Society for Microbiology 1989; 107.
14. Teasley DG, Gerding DN, Olson MM. et al. Prospective randomized trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet 1983; 1043-6.
15. Wilcox MH, Spencer RC. Clostridium difficile infection: Responses, relapses, and reinfection. J Hosp Infect 1992;22:85-92.
16. Drapkin MS, Worthington MG, Chang TW, et al. Clostridium difficile colitis mimicking acute peritonitis. Arch Surg 1985; 120:1321-2.
17. Tedesco FJ. Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination. Gastroenterology 1979;77:295-7.
18. Morris JB, Zollinger RM, Stellato TA. Role of surgery in antibiotic-induced pseudomembranous enterocolitis. Am J Surg 1990;160:535-9.
19. Warny M, Vaerman JP, Avesani V, et al. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun 1994;62:384-9.